# ARTBIO

**Canonical:** https://apis.io/providers/artbio/  
**Website:** https://artbio.com/  
**APIs profiled:** 0

ARTBIO is a clinical-stage radiopharmaceutical company developing a new class of targeted Alpha Radioligand Therapies (ARTs) built on the lead-212 (212Pb) isotope. Founded in 2021 out of research at the University of Oslo and Norway's Radium Hospital by Roy Larsen and Oyvind Bruland - the scientific co-founders behind Xofigo - the company pairs a differentiated oncology pipeline with its proprietary AlphaDirect isotope-production technology, a first-of-its-kind 212Pb isolation method intended to enable distributed manufacturing and reliable supply of alpha radioligand therapies. Its lead program AB001 (212Pb-NG001) is in first-in-human Phase 1 trials in metastatic castration-resistant prostate cancer, with additional preclinical and discovery programs across breast, head and neck, lung, pancreatic and other solid tumors. ARTBIO operates from Cambridge, Massachusetts and Oslo, is backed by F-Prime Capital, Third Rock Ventures, Omega Funds, Sofinnova Partners, B Capital, ARE and QIA, and is privately held. It publishes no public API, developer portal, SDK or machine-readable specification - software is not its product.

## Kin Score — 11.1 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 11.1).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Artbio Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biotechnology, Pharmaceuticals, Radiopharmaceuticals, Oncology, Clinical Trials, Life Sciences, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/artbio/). Scores are computed from the provider's own public artifacts under a published rubric.